Homocysteine-lowering vitamins and cardiovascular mortality: Are they really effective?

International Journal of Cardiology

Volumn 128, Issue 3, 2008, Pages 432-433

  Celik, Turgay ^a   Iyisoy, Atila ^a   Yuksel, U Cagdas ^b   Isik, Ersoy ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Sarikamis Army District Hospital Turkey   (Turkey)

Author keywords

Cardiovascular mortality; Folic acid treatment; Homocysteine

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; PLACEBO; VITAMIN B GROUP;

AMINO ACID BLOOD LEVEL; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG EFFECT; HEART INFARCTION; HOMOCYSTINURIA; HUMAN; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; ST SEGMENT ELEVATION; STROKE;

CARDIOVASCULAR DISEASES; FOLIC ACID; HOMOCYSTEINE; HUMANS; VITAMINS;

EID: 48149087259     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.05.044     Document Type: Article

References (5)

1. Fernandez-Miranda C., Yebra M., Aranda J.L., et al. Effect of folic acid treatment on carotid intima-media thickness of patients with coronary disease. Int J Cardiol 118 3 (Jun 12 2007) 345-349
2. Merritt J.C., and Foody J.M. Nonlipid cardiovascular risk factors. In: Griffin B.P., and Topol E.J. (Eds). Manual of Cardiovascular Medicine. 2nd ed. (2004), Lippincott Williams & Wilkins Company 550-553
3. Rosenson R.S., and Kang D.S. Overview of homocyteine. In: Rose B.D. (Ed). UpToDate (2005), UpToDate, Wellesley
4. Lonn E., et al., on behalf of the HOPE-2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354 (2006) 1567-1577
5. Bonaa K.H., Njolstad I., Ueland P.M., et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354 (2006) 1578-1588